Announcement under Regulation 30 (LODR)-Press Release / Media Release
Rays Of Belief Limited operates in Hospital within the Healthcare sector.
14 historical price candles were omitted because the exchange source has not been verified.
Structured signal from quality, growth, valuation and momentum.
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Ratios derive from annual statements, which haven't been ingested yet.
Corporate actions, results dates and filings will appear here once ingested.
No scheme among the 32 fund houses on record reported a position in Rays Of Belief Limited. Portfolios are published monthly by each AMC; coverage is still partial.
| Holder (%) | Jun 2026 |
|---|---|
| 68.77% | |
| 8.34% | |
| 11.24% | |
| Government | 0% |
| 11.65% | |
| No. of shareholders | 9,400 |
Promoter holding up 0 percentage points since Jun 2026.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 16 Sept 2026 | SACHCHIYAY STOCK BROKING PRIVATE LIMITED | Bulk | NSE | Sell | 2,75,000 | ₹217.15 | ₹5.97 Cr |
| 16 Sept 2026 | PROGNOSIS SECURITIES PVT. LTD | Bulk | NSE | Buy | 1,70,430 | ₹217.75 | ₹3.71 Cr |
| 9 Sept 2026 | RAMESH KUMAR | Bulk | NSE | Buy | 1,17,973 | ₹235.28 | ₹2.78 Cr |
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
Documents link to external sources (exchange filings, company investor pages).
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH | ₹91,573 Cr | ₹95,052 Cr | ₹8,712 Cr | ₹2,318 Cr | 26.8% | ₹1,457 Cr | 17.2% | 13.8% | 14.3% | -110 |
| Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS | ₹91,552 Cr | ₹1,02,105 Cr | ₹10,336 Cr | ₹2,611 Cr | 25.3% | ₹917 Cr | 8.9% | 12.5% | 12.8% | 38 |
| Fortis Healthcare LimitedFORTISFORTIS | ₹59,268 Cr | ₹62,140 Cr | ₹9,506 Cr | ₹2,131 Cr | 22.8% | ₹1,048 Cr | 11.7% | 13% | 11.1% | -99 |
| Aster Dm Healthcare LimitedASTERDMASTERDM | ₹36,728 Cr | ₹37,429 Cr | ₹4,876 Cr | ₹958 Cr | 19.4% | ₹319 Cr | 9.2% | 11.9% | 9.7% | -112 |
| Global Health LimitedMEDANTAMEDANTA | ₹36,498 Cr | ₹37,688 Cr | ₹4,683 Cr | ₹979 Cr | 20.8% | ₹556 Cr | 12.6% | 16.9% | 15.1% | -26 |
| Narayana Hrudayalaya Ltd.NHNH | ₹35,594 Cr | ₹40,460 Cr | ₹9,072 Cr | ₹1,749 Cr | 20.5% | ₹816 Cr | 10.2% | 15.1% | 19.7% | -181 |
| Krishna Institute Of Medical Sciences LimitedKIMSKIMS | ₹29,457 Cr | ₹32,701 Cr | ₹4,213 Cr | ₹833 Cr | 20.5% | ₹205 Cr | 6.2% | 9.5% | 11% | -50 |
| Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE | ₹15,420 Cr | ₹15,578 Cr | ₹2,207 Cr | ₹612 Cr | 27.4% | ₹148 Cr | 8.1% | 10.1% | 6.8% | -76 |
| Rainbow Childrens Medicare LimitedRAINBOWRAINBOW | ₹13,003 Cr | ₹13,003 Cr | ₹1,820 Cr | ₹575 Cr | 32% | ₹285 Cr | 16.5% | 18.2% | 17.9% | -73 |
| Park Medi World LimitedPARKHOSPSPARKHOSPS | ₹11,696 Cr | ₹11,924 Cr | ₹1,679 Cr | ₹444 Cr | 26.5% | ₹258 Cr | 16.3% | 21.4% | 16.7% | -2 |
| Healthcare Global Enterprises LimitedHCGHCG | ₹9,984 Cr | ₹10,895 Cr | ₹2,627 Cr | ₹480 Cr | 18.3% | ₹23 Cr | 0.9% | 9.1% | 1.2% | -93 |
| Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH | ₹9,965 Cr | ₹10,218 Cr | ₹1,334 Cr | ₹310 Cr | 24.2% | ₹174 Cr | 14.1% | 12.3% | 10% | -26 |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Newspaper Publication
Unaudited Financial Result For The Quarter Ended June 30, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On September 28, 2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Acquisition
Announcement under Regulation 30 (LODR)-Acquisition
Closure of Trading Window
| Date | Category | Subject | Filing |
|---|---|---|---|
| 1 Oct 2026, 3:35 pm | Company Update Press Release / Media Release | Announcement under Regulation 30 (LODR)-Press Release / Media Release | |
| 29 Sept 2026, 4:30 pm | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 28 Sept 2026, 7:35 pm | Result Financial Results | Unaudited Financial Result For The Quarter Ended June 30, 2026 |
| 28 Sept 2026, 7:31 pm | Board Meeting Outcome of Board Meeting | Board Meeting Outcome for Outcome Of Board Meeting Held On September 28, 2026. |
| 21 Sept 2026, 7:01 pm | Company Update Press Release / Media Release | Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| 19 Sept 2026, 6:02 pm | Company Update Acquisition | Announcement under Regulation 30 (LODR)-Acquisition |
| 17 Sept 2026, 5:29 pm | Company Update Acquisition | Announcement under Regulation 30 (LODR)-Acquisition |
| 10 Sept 2026, 5:19 pm | Insider Trading / SAST Closure of Trading Window | Closure of Trading Window |
Standalone figures · ₹ crore
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| 22 | 31 | 36 | |
| 31 | 31 | 36 | |
| Operating profit (EBITDA) | -8 | 0 | 1 |
| OPM % | -38.2% | 0.3% | 2.3% |
| Depreciation | — | — | — |
| Interest | 0 | 0 | 1 |
| 0 | 0 | 0 | |
| Profit before tax | -8 | 0 | 0 |
| Tax | 0 | -1 | -6 |
| Tax % | 0% | -750% | -1,580% |
| -8 | 1 | 6 | |
| PAT margin % | -38.2% | 2.8% | 16.1% |
| EPS (₹) | — | — | — |
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| -7 | 2 | -2 | |
| 2 | -3 | -2 | |
| Cash from financing | 8 | 1 | 5 |
| Net cash flow | 2 | 0 | 1 |
| Free cash flow | -8 | 1 | -4 |
| CFO / Operating profit % | — | — | -220.7% |